Jun 09, 2021 / 03:40PM GMT
Graig Suvannavejh - Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
Okay. Good afternoon, everyone, and welcome to the 4:40 p.m. session here on day 2 at the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover U.S. and European biopharma names here at the firm. It's my great pleasure to be hosting BioXcel Therapeutics in a fireside chat. And with that, joining from the company are CEO, Vimal Mehta; and Chief Commercialization Officer; William Kane. Gentlemen, it's good to see you both, and welcome.
Vimal D. Mehta - BioXcel Therapeutics, Inc. - Founder, CEO, President, & Director
Thank you, Graig.
William P. Kane - BioXcel Therapeutics, Inc. - Executive VP & Chief Commercial Officer
Thank you, Graig.
Graig Suvannavejh - Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
Okay, very well. Well, my sense is there's probably a number of
BioXcel Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot